Prognostic factors of childhood and adolescent acute myeloid leukemia (AML) survival: Evidence from four decades of US population data
Authors:
- 1 October 2015
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 39 (5) , 720-726
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysisAnnals of Oncology, 2014
- Prognostic Factors in Pediatric Acute Myeloid LeukemiaCurrent Hematologic Malignancy Reports, 2010
- Single Nucleotide Polymorphism in the Mutational Hotspot ofWT1Predicts a Favorable Outcome in Patients With Cytogenetically Normal Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesBlood, 2009
- Trends in childhood cancer incidence in the U.S. (1992–2004)Cancer, 2007
- Prognostic Factors and Risk-Based Therapy in Pediatric Acute Myeloid LeukemiaThe Oncologist, 2007
- The World Health Organization (WHO) classification of the myeloid neoplasmsBlood, 2002
- Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemiaBlood, 2001
- GlutathioneS-Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid LeukemiaJournal of Clinical Oncology, 2001
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976